Contact
Print
Oncology
PSI is a leading full-service CRO operating globally.
98% of PSI-managed clinical trials complete patient enrollment on or ahead of schedule.
PSI's exceptional repeat and referral business rate distinguishes PSI in the market place as a "no-nonsense" CRO that delivers across trials of all sizes and levels of complexity.
PSI has successfully performed studies in the following cancer indications:
PSI has experience with the following types of cancer therapeutics:
|
|
PSI has managed Phase I, II and III cancer studies.
PSI has run studies in neoadjuvant, adjuvant and advanced disease settings.
PSI employs physicians as full-time monitors and project managers, most of whom are board certified specialists, including medical oncologists.